Unlisted
| Company Name | (주)툴젠 |
| English Name | ToolGen Incorporated |
| Business Reg. No. | 1088118555 |
| CEO | 유종상 |
| Address | 서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크,8층 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 701 |
| Main Products | CRISPR/Cas9 유전자가위 |
| Established | 19991008 |
| Phone | 02-3660-1334 |
| Website | toolgen.com |
| Regular Employees | 82persons |
| Corp. Reg. No. | 1101111785827 |
Venture Certified
| 연구개발기업 | 1999-10-08 ~ 2001-06-30 | 1999112281-1771 | 1999-10-08 |
| 연구개발기업 | 2001-06-15 ~ 2003-06-14 | 011522021101103 | 1999-10-08 |
| 연구개발기업 | 2003-06-15 ~ 2005-06-14 | 031522021300192 | 1999-10-08 |
| 연구개발기업 | 2005-06-15 ~ 2007-06-14 | 051522021400227 | 1999-10-08 |
| 연구개발유형 | 2007-06-15 ~ 2009-06-14 | 20070101791 | 1999-10-08 |
| 연구개발유형 | 2009-08-21 ~ 2011-08-20 | 20090107614 | 1999-10-08 |
| 연구개발유형 | 2011-08-21 ~ 2013-08-20 | 20110105384 | 1999-10-08 |
| 연구개발유형 | 2013-08-21 ~ 2015-08-20 | 20130108426 | 1999-10-08 |
| 연구개발유형 | 2015-08-21 ~ 2017-08-20 | 20150109451 | 1999-10-08 |
| 연구개발유형 | 2017-08-21 ~ 2019-08-20 | 20170111260 | 1999-10-08 |
| 연구개발유형 | 2019-08-21 ~ 2021-08-20 | 20190111831 | 1999-10-08 |
| 벤처투자유형 | 2021-08-21 ~ 2024-08-20 | 20210721010054 | 1999-10-08 |
| 벤처투자유형 | 2024-08-21 ~ 2027-08-20 | 20240903010026 | 1999-10-08 |
Revenue CAGR -17.7%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 8.9B | 11B | 7.4B | 16B |
| Operating Profit | -218B | -171B | -194B | -207B |
| Net Profit | 62B | -423B | -182B | -207B |
| Total Assets | 755B | 935B | 754B | 877B |
| Total Liabilities | 170B | 634B | 50B | 30B |
| Total Equity | 584B | 301B | 705B | 847B |
Operating Loss: Op. profit -218B
▼ 22.4%
▼ 14.3%
▼ 34.6%
▼ 60.4%
▲ 116.8%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 유종상 | 사내이사 | CEO 대표이사 | - |
| 김유리 | 사내이사 | CLO IP전략 본부장 | - |
| 김재우 | 기타비상무이사 | 경영자문 | - |
| 김진수 | 기타비상무이사 | 경영자문 | - |
| 홍성준 | 기타비상무이사 | 이사회 의장 | - |
| 민경성 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| Regular Employees | 82persons |
| CEO | 유종상 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 강서구",
"ceo_name": "유종상",
"certificate": [
{
"cert_number": "1999112281-1771",
"changes": "",
"disclosure_date": "1999-10-08",
"first_cert_date": "1999-10-08",
"no": "1",
"type": "연구개발기업",
"valid_period": "1999-10-08 ~ 2001-06-30"
},
{
"cert_number": "011522021101103",
"changes": "",
"disclosure_date": "2001-06-15",
"first_cert_date": "1999-10-08",
"no": "2",
"type": "연구개발기업",
"valid_period": "2001-06-15 ~ 2003-06-14"
},
{
"cert_number": "031522021300192",
"changes": "",
"disclosure_date": "2003-06-15",
"first_cert_date": "1999-10-08",
"no": "3",
"type": "연구개발기업",
"valid_period": "2003-06-15 ~ 2005-06-14"
},
{
"cert_number": "051522021400227",
"changes": "",
"disclosure_date": "2005-06-15",
"first_cert_date": "1999-10-08",
"no": "4",
"type": "연구개발기업",
"valid_period": "2005-06-15 ~ 2007-06-14"
},
{
"cert_number": "20070101791",
"changes": "",
"disclosure_date": "2007-06-12",
"first_cert_date": "1999-10-08",
"no": "5",
"type": "연구개발유형",
"valid_period": "2007-06-15 ~ 2009-06-14"
},
{
"cert_number": "20090107614",
"changes": "",
"disclosure_date": "2009-08-21",
"first_cert_date": "1999-10-08",
"no": "6",
"type": "연구개발유형",
"valid_period": "2009-08-21 ~ 2011-08-20"
},
{
"cert_number": "20110105384",
"changes": "",
"disclosure_date": "2011-08-24",
"first_cert_date": "1999-10-08",
"no": "7",
"type": "연구개발유형",
"valid_period": "2011-08-21 ~ 2013-08-20"
},
{
"cert_number": "20130108426",
"changes": "",
"disclosure_date": "2013-08-20",
"first_cert_date": "1999-10-08",
"no": "8",
"type": "연구개발유형",
"valid_period": "2013-08-21 ~ 2015-08-20"
},
{
"cert_number": "20150109451",
"changes": "",
"disclosure_date": "2015-09-09",
"first_cert_date": "1999-10-08",
"no": "9",
"type": "연구개발유형",
"valid_period": "2015-08-21 ~ 2017-08-20"
},
{
"cert_number": "20170111260",
"changes": "",
"disclosure_date": "2017-09-22",
"first_cert_date": "1999-10-08",
"no": "10",
"type": "연구개발유형",
"valid_period": "2017-08-21 ~ 2019-08-20"
},
{
"cert_number": "20190111831",
"changes": "",
"disclosure_date": "2019-10-14",
"first_cert_date": "1999-10-08",
"no": "11",
"type": "연구개발유형",
"valid_period": "2019-08-21 ~ 2021-08-20"
},
{
"cert_number": "20210721010054",
"changes": "",
"disclosure_date": "2021-07-21",
"first_cert_date": "1999-10-08",
"no": "12",
"type": "벤처투자유형",
"valid_period": "2021-08-21 ~ 2024-08-20"
},
{
"cert_number": "20240903010026",
"changes": "대표자",
"disclosure_date": "2024-09-03",
"first_cert_date": "1999-10-08",
"no": "13",
"type": "벤처투자유형",
"valid_period": "2024-08-21 ~ 2027-08-20"
}
],
"company_name": "㈜툴젠",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 3942547000,
"cost_of_sales": 185065000,
"current_assets": 56539556000,
"current_liabilities": 3858054000,
"gross_profit": 558399000,
"net_income": -18137444000,
"net_income_bs": -18137444000,
"non_current_assets": 18929022000,
"non_current_liabilities": 1102936000,
"non_operating_expenses": 172692000,
"non_operating_income": 1376020000,
"operating_profit": -19340772000,
"revenue": 743464000,
"sga_expenses": 19899171000,
"total_assets": 75468578000,
"total_equity": 70507589000,
"total_liabilities": 4960989000
},
"2023": {
"capital_stock": 3959637000,
"cost_of_sales": 168445000,
"current_assets": 66001252000,
"current_liabilities": 1770505000,
"gross_profit": 923740000,
"net_income": -42039061000,
"net_income_bs": -42039061000,
"non_current_assets": 27768122000,
"non_current_liabilities": 61585073000,
"non_operating_expenses": 27500209000,
"non_operating_income": 2258378000,
"operating_profit": -16797230000,
"revenue": 1092186000,
"sga_expenses": 17720970000,
"total_assets": 93769374000,
"total_equity": 30413797000,
"total_liabilities": 63355578000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "2,500,000,000",
"changes": "2,500,000,000",
"date": "2023-11-02"
},
{
"amount": "3,297,000,000",
"changes": "3,297,000,000",
"date": "2016-10-14"
}
],
"main_products": "CRISPR/Cas9 유전자가위",
"phone": "02-3660-****",
"years": [
2023,
2022
]
}Data Quality: 9/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-03-04 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |